221 related articles for article (PubMed ID: 11313679)
1. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.
Serke S; Johnsen HE
Bone Marrow Transplant; 2001 Mar; 27(5):463-70. PubMed ID: 11313679
[TBL] [Abstract][Full Text] [Related]
2. JACIE accreditation in paediatric haemopoietic SCT.
Cornish JM
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S82-6. PubMed ID: 18978752
[TBL] [Abstract][Full Text] [Related]
3. Regulatory aspects of cellular therapy product in Europe: JACIE accreditation in a processing facility.
Caunday O; Bensoussan D; Decot V; Bordigoni P; Stoltz JF
Biomed Mater Eng; 2009; 19(4-5):373-9. PubMed ID: 20042804
[TBL] [Abstract][Full Text] [Related]
4. [JACIE: from guidelines to clinical practice and continuous quality improvement, the Léon-Bérard cancer center experience].
Donot PE
Bull Cancer; 2009; 96(7):797-804. PubMed ID: 19592332
[TBL] [Abstract][Full Text] [Related]
5. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
Warkentin PI;
Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235
[TBL] [Abstract][Full Text] [Related]
6. [Happy birthday to Joint Accreditation Committee for ISCT Europe and EBMT].
Caunday O; Faucher C; Milpied N; Chabannon C
Med Sci (Paris); 2010; 26(6-7):652-4. PubMed ID: 20619170
[TBL] [Abstract][Full Text] [Related]
7. Donor-derived hematopoietic stem cells in organ transplantation: technical aspects and hurdles yet to be cleared.
Hervé P
Transplantation; 2003 May; 75(9 Suppl):55S-57S. PubMed ID: 12819493
[TBL] [Abstract][Full Text] [Related]
8. Quality assessment of autologous hematopoietic blood progenitor and stem cell grafting: a prospective registration study.
Johnsen HE; Lanza F
J Biol Regul Homeost Agents; 2002; 16(4):272-88. PubMed ID: 12597644
[No Abstract] [Full Text] [Related]
9. Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis.
Zahnd D; Leibundgut K; Zenhäusern R; Pabst T; Fontana S; Schneider R; Tobler A; Zwicky C
Bone Marrow Transplant; 2004 Nov; 34(10):847-53. PubMed ID: 15517005
[TBL] [Abstract][Full Text] [Related]
10. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
11. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering.
Sutherland DR; Anderson L; Keeney M; Nayar R; Chin-Yee I
J Hematother; 1996 Jun; 5(3):213-26. PubMed ID: 8817388
[TBL] [Abstract][Full Text] [Related]
12. Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure.
Massin F; Huili C; Decot V; Stoltz JF; Bensoussan D; Latger-Cannard V
Biomed Mater Eng; 2015; 25(1 Suppl):27-39. PubMed ID: 25538053
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods.
Gajkowska A; Oldak T; Jastrzewska M; Machaj EK; Walewski J; Kraszewska E; Pojda Z
Folia Histochem Cytobiol; 2006; 44(1):53-60. PubMed ID: 16584093
[TBL] [Abstract][Full Text] [Related]
14. Autologous peripheral blood stem cell transplantation: predictors for haematopoietic reconstitution.
Bedi R; Kumar L; Kochupillai V
Natl Med J India; 2003; 16(5):255-9. PubMed ID: 14680281
[TBL] [Abstract][Full Text] [Related]
15. Real-time process/quality control for HPC processing.
Arpagaus M; Leibundgut EO; Zbären K; Brunold C; Ischi E; Tobler A; Zwicky C
Cytotherapy; 2004; 6(5):505-13. PubMed ID: 15512917
[TBL] [Abstract][Full Text] [Related]
16. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study.
Gratama JW; Kraan J; Keeney M; Sutherland DR; Granger V; Barnett D
Cytotherapy; 2003; 5(1):55-65. PubMed ID: 12745591
[TBL] [Abstract][Full Text] [Related]
17. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
18. External quality assessment in clinical cell analysis by flow cytometry. Why is it so important?
Siftar Z; Paro MM; Sokolić I; Nazor A; Mestrić ZF
Coll Antropol; 2010 Mar; 34(1):207-17. PubMed ID: 20432753
[TBL] [Abstract][Full Text] [Related]
19. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
[TBL] [Abstract][Full Text] [Related]
20. Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE).
Samson D; Slaper-Cortenbach I; Pamphilon D; McGrath E; McDonald F; Urbano Ispizua A
Bone Marrow Transplant; 2007 Feb; 39(3):133-41. PubMed ID: 17245423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
